Diagnostic and therapeutics for osteoporosis

Details for Australian Patent Application No. 2004263184 (hide)

Owner Interleukin Genetics, Inc.

Inventors Martha, Paul; Duff, Gordon W.; Kornman, Kenneth; Van Dijk, Simon

Agent Cullens

Pub. Number AU-B-2004263184

PCT Pub. Number WO2005/013809

Priority 60/493,861 08.08.03 US

Filing date 9 August 2004

Wipo publication date 17 February 2005

Acceptance publication date 2 December 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

23 February 2006 PCT application entered the National Phase

  PCT publication WO2005/013809 Priority application(s): WO2005/013809

2 December 2010 Application Accepted

  Published as AU-B-2004263184

31 March 2011 Standard Patent Sealed

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263190-Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases

2004263179-Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain